Jane Street’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Sell |
186,986
-144,199
| -44% | -$924K | ﹤0.01% | 2652 |
|
|
2025
Q1 | $1.17M | Sell |
331,185
-434,290
| -57% | -$1.54M | ﹤0.01% | 2858 |
|
|
2024
Q4 | $2.89M | Buy |
765,475
+421,302
| +122% | +$1.59M | ﹤0.01% | 1689 |
|
|
2024
Q3 | $1.12M | Sell |
344,173
-146,934
| -30% | -$476K | ﹤0.01% | 3236 |
|
|
2024
Q2 | $933K | Sell |
491,107
-536,513
| -52% | -$1.02M | ﹤0.01% | 3764 |
|
|
2024
Q1 | $2.92M | Sell |
1,027,620
-129,545
| -11% | -$368K | ﹤0.01% | 1845 |
|
|
2023
Q4 | $17M | Buy |
1,157,165
+555,877
| +92% | +$8.18M | ﹤0.01% | 623 |
|
|
2023
Q3 | $11M | Buy |
601,288
+127,895
| +27% | +$2.34M | ﹤0.01% | 778 |
|
|
2023
Q2 | $10.2M | Buy |
473,393
+208,535
| +79% | +$4.5M | ﹤0.01% | 967 |
|
|
2023
Q1 | $7.77M | Buy |
264,858
+128,301
| +94% | +$3.76M | ﹤0.01% | 867 |
|
|
2022
Q4 | $5.05M | Buy |
+136,557
| New | +$5.05M | ﹤0.01% | 1157 |
|
|
2022
Q3 | – | Sell |
-179,602
| Closed | -$3.46M | – | 5706 |
|
|
2022
Q2 | $3.46M | Buy |
179,602
+150,356
| +514% | +$2.9M | ﹤0.01% | 1414 |
|
|
2022
Q1 | $376K | Buy |
+29,246
| New | +$376K | ﹤0.01% | 4059 |
|